Welcome to the
Hepatitis B Foundation
Hepatic ALT Flares Linked to HBsAg Clearance
July 6 – Hepatic alanine aminotransferase (ALT) flares are associated with rapid decline and greater annual reductions of hepatitis B surface antigen (HBsAg) in patients with chronic hepatitis B virus who achieve HBsAg seroclearance, say Japanese researchers. Read more.
dlDNA Marks Progression of HBV-Related Liver Disease
July 6 – The level of serum duplex-linear DNA (dlDNA) increases markedly with liver disease progression and the development of hepatocellular carcinoma in patients with chronic hepatitis B, suggests research published in Gut. Read more.
Syringe Exchange Program Highlights Infectious Disease Levels in West Virginia
July 6 – West Virginia (WV) unveils the state’s first syringe exchange program in an effort to reduce overdose deaths and the spread of infectious diseases. WA has the highest rate of new hepatitis B cases in the country, and the second highest rate of hepatitis C cases. Read more.
Unhygienic Dental Practices Puts 12,000 Australians at HIV & Hepatitis Risk
July 6 – More than 11,000 dental patients in the Australian city of Sydney may have been exposed to HIV and viral hepatitis because of unhygienic practices at four clinics across the city over a number of years. Read more.
Learn more about HBV and earn CME credits as well! This educational webinar is a collaborative effort between CME Outfitter LLC, ProPatient LLC, and the Hepatitis B Foundation. Download now.
Institute Assembles Team of 'All-Star Researchers' to Cure Hepatitis B
April 6– The Baruch S. Blumberg Institute has recruited a new team of nationally renowned, “all Star researchers” who will focus exclusively on developing a cure for hepatitis B, with a goal for breakthrough therapies within the next three years. Read more.
Page last modified July 6, 2015